title: [Combined treatment of patients with prostatic adenoma and overactive bladder].
abstract: Of late, we observe a trend to a progressive rise of overactive bladder (OB) morbidity with age. M-cholinolytic drugs are most effective in management of OB but old patients with prostatic adenoma (PA) and comorbid pathology have a risk of acute urinary retention and serious side effects. We have the experience in combined treatment of 30 old patients with PA and OB with M-cholinolytic and alpha-adrenoblocker. The results of the treatment show its efficacy and absence of complications in the control of residual urine for 3 months. Combination of M-cholinolytic with alpha-adreboblocker significantly reduced daily diuresis, improved an accumulation function of the bladder and life quality.
authors.forename: V A
authors.initials: VA
authors.lastname: Maksimov
authors.forename: L A
authors.initials: LA
authors.lastname: Khodyreva
authors.forename: A A
authors.initials: AA
authors.lastname: Dudareva
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Al'bitskaia
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000367:Age Factors; D000368:Aged; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D004231:Diuresis / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D011788:Quality of Life; D053201:Urinary Bladder, Overactive / Q000150:complications / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D016055:Urinary Retention / Q000139:chemically induced / Q000401:mortality / Q000503:physiopathology
chemical_list: D000317:Adrenergic alpha-Antagonists; D018680:Cholinergic Antagonists